J1171Inj, hydromorphone, 0.1 mg
Published CMS Medicare Part B payment-limit context for J1171, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$0.136
per 0.1 MG · Medicare Part B
Up 34.7%from $0.101 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$0.1477$0.0773
2024-Q4: $0.085; 2025-Q1: $0.089; 2025-Q2: $0.137; 2025-Q3: $0.085; 2025-Q4: $0.095; 2026-Q1: $0.14; 2026-Q2: $0.101; 2026-Q3: $0.136
Ingredient appears in FDA shortage dataFDA’s latest completed shortage data includes an affected record matching the Hydromorphone Hydrochloride ingredient family (FDA data as of August 20, 2026).
Hydromorphone Hcl
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.